Conditions: Open-Angle Glaucoma Ocular Hypertension
Keywords: Ocular hypertension
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 43
Healthy volunteers: no

Brief summary:
The objective of this study is to investigate the pharmacodynamics (as expressed in intraocular pressure \[IOP\]) of two formulations of tafluprost 0.0015% eyedrops (preserved and unpreserved) in patients with open-angle glaucoma or ocular hypertension.

The primary aim of this study is to show that IOP reduction between the two formulations is equivalent at the end of the 4 week treatment period.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Tafluprost 0.0015%
Intervention descriptions: intervention 1: Eye drops, 0.015 mg/ml, once daily to affected eye(s)

Protocol document: